Results of long-term human growth hormone theraph for pituitary dwarfism
-
- SHIZUME KAZUO
- Department of Endocrinology and Endocrine Research Laboratory, Toranomon Hospital Third Department of Internal Medicine, University of Tokyo Faculty of Medicine
-
- MATSUZAKI FUKASHI
- Department of Endocrinology and Endocrine Research Laboratory, Toranomon Hospital Third Department of Internal Medicine, University of Tokyo Faculty of Medicine
-
- IRIE MINORU
- Department of Endocrinology and Endocrine Research Laboratory, Toranomon Hospital Third Department of Internal Medicine, University of Tokyo Faculty of Medicine
-
- OSAWA NAKAAKI
- Department of Endocrinology and Endocrine Research Laboratory, Toranomon Hospital Third Department of Internal Medicine, University of Tokyo Faculty of Medicine
書誌事項
- タイトル別名
-
- Results of Long-Term Human Growth Hormone Therapy for Pituitary Dwarfism
この論文をさがす
抄録
Since 1961, 14 patients with pituitary dwarfism were treated with human growth hormone (HGH). In this report, the result of long term treatment for more than 2 and a half years in five patients is reported. The dose of HGH was 2-4 mg three times a week. In the first six months, a marked increase in height was observed in all cases. The increase declined gradually and in some cases HGH became almost ineffective. In such cases anti-HGH antibody was observed in the patient's blood. Bone age/height age progress ratio was less than one in most cases. No side effect was observed except pain at the site of injection. In two cases, height reached to the level above-2-D of the height of normal adult.
収録刊行物
-
- Endocrinologia Japonica
-
Endocrinologia Japonica 17 (4), 297-306, 1970
一般社団法人 日本内分泌学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390282681276951296
-
- NII論文ID
- 130000958376
-
- NII書誌ID
- AA00635052
-
- ISSN
- 21856370
- 00137219
-
- NDL書誌ID
- 8508560
-
- PubMed
- 5537137
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- NDL
- Crossref
- PubMed
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可